The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type-Reference-Cited by-同舟云学术

The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type

Published:2016-08-09 Issue:36 Volume:7 Page:58396-58404
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Lei¹,Li Sucai¹,Jia Sisi¹,Nan Feifei¹,Li Zhaoming¹,Cao Jingyu¹,Fan Shanshan¹,Zhang Chao¹,Su Liping²,Wang Jinghua³,Xue Hongwei⁴,Zhang Mingzhi¹

Affiliation:

1. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China

2. Department of Hematology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China

3. Department of Oncology, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu, China

4. Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase;Future Oncology;2024-07-23

2. Phase II Study of Peg-Asparaginase, Etoposide, Gemcitabine (PEG) Followed by Involved- Field Radiation Therapy in Early-Stage Extranodal Natural Killer/T-Cell Lymphoma;2023-06-26

3. A neutrophil/lymphocyte Ratio as a Significant Predictor for Patients with low-risk and early-stage Extranodal NK-T-cell Lymphoma;Indian Journal of Hematology and Blood Transfusion;2022-11-27

4. The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma;Journal of Cancer Research and Clinical Oncology;2022-07-20

5. Induction with MEDA regimen and consolidation with Auto‐HSCT for stage IV NKTCL patients: A prospective multicenter study;International Journal of Cancer;2022-06-09